drugset / Trial / NCT04989829

Effect of Omeprazole on the Pharmacokinetics of SHR6390 in Healthy Subjects

NCT04989829

Phase 1 Completed 20 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

This is a one-arm, fixed-sequence study to compare the pharmacokinetic profiles of SHR6390 in absence and presence of prior administration of proton pump inhibitor Omeprazole. The increased gastric pH achieved by the treatment with multiple doses of Omeprazole might affect the absorption process of SHR6390.

Timeline

Start
2021-12-27
Primary completion
2022-01-26
Completion
2022-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject Dalpiciclib Small molecule Oral
Subject Omeprazole Other / unclassified

Indications